Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 725.50% | 24.41% | -101.43% | -85.10% | -12.87% |
| Total Depreciation and Amortization | 3.41% | 27.59% | 66.20% | 45.44% | 26.34% |
| Total Amortization of Deferred Charges | -47.46% | -6.27% | 81.72% | 129.30% | 180.46% |
| Total Other Non-Cash Items | -536.61% | -438.17% | -352.04% | -192.30% | 2.87% |
| Change in Net Operating Assets | 260.22% | 159.96% | 147.80% | 126.57% | 63.01% |
| Cash from Operations | 452.87% | 108.52% | -62.94% | -27.60% | 109.83% |
| Capital Expenditure | -114.76% | -7.94% | 43.08% | 61.03% | 72.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.43% | -100.32% | -100.23% | -100.24% | -100.25% |
| Cash from Investing | -0.87% | -101.68% | -100.45% | -100.83% | -101.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 73.69% | 7.27% | -206.52% | -528.37% | -- |
| Issuance of Common Stock | -0.85% | -31.37% | -43.99% | -44.71% | -45.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 95.55% | 99.78% | 99.80% | 99.71% | 99.62% |
| Cash from Financing | 76.94% | 39.01% | -2.78% | -18.72% | -36.41% |
| Foreign Exchange rate Adjustments | 132.22% | 102.23% | 95.22% | 63.93% | -194.56% |
| Miscellaneous Cash Flow Adjustments | -- | -220.00% | -209.09% | -220.00% | -- |
| Net Change in Cash | 237.51% | 9.08% | -171.51% | -179.80% | -190.57% |
